For the quarter ending 2025-12-31, STE made $1,496,200K in revenue. $192,900K in net income. Net profit margin of 12.89%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenues | 1,496,200 | 1,460,300 | 1,391,100 | 1,480,531 |
| Cost of product and service sold-Product | 418,200 | 390,800 | 359,700 | 433,399 |
| Cost of product and service sold-Service | 422,500 | 423,600 | 403,400 | 405,921 |
| Cost of revenues | - | - | - | 689,056 |
| Total cost of revenues | 840,700 | 814,400 | 763,100 | - |
| Gross profit | 655,500 | 645,900 | 628,000 | 641,211 |
| Selling, general, and administrative | 352,300 | 349,700 | 353,800 | 333,902 |
| Research and development | 29,500 | 28,200 | 26,400 | 27,686 |
| Litigation settlement, loss | - | - | - | 48,150 |
| Restructuring costs | 400 | 2,200 | 1,800 | 15,322 |
| Total operating expenses | 382,300 | 380,100 | 382,000 | 425,060 |
| Income from operations | 273,200 | 265,800 | 246,000 | 216,151 |
| Interest expense | 14,900 | 14,900 | 15,900 | 23,750 |
| Interest income and miscellaneous expense | 2,900 | 2,400 | 1,800 | 3,533 |
| Loss (gain) on sale of businesses and equity investment, net | - | -200 | 0 | 1,377 |
| Other expense (income), net | -3,300 | - | - | - |
| Total non-operating expenses, net | -15,300 | -12,700 | -14,100 | -18,840 |
| Income before income tax expense | 257,800 | 253,100 | 231,900 | 197,311 |
| Income tax expense | 63,500 | 60,600 | 53,900 | 50,450 |
| Income from continuing operations, net of income tax | 194,300 | 192,500 | 178,000 | 146,861 |
| Product | - | - | - | 31,968 |
| Product | - | - | - | 17,573 |
| Gross profit | - | - | - | 14,395 |
| Selling, general, and administrative | - | - | - | 6,733 |
| Goodwill impairment loss | - | - | - | 0 |
| Research and development | - | - | - | 185 |
| Income (loss) from operations-Discontinued Operations Dental Segment-Discontinued Operations Heldforsale | - | - | - | 7,478 |
| Non-operating expenses (income), net-Discontinued Operations Dental Segment-Discontinued Operations Heldforsale | - | - | - | 1 |
| Loss on classification as held for sale | - | - | - | 3,499 |
| Income (loss) before income tax expense | - | - | - | -5,785 |
| Income tax benefit | - | - | - | -4,999 |
| Income (loss) from discontinued operations, net of tax, attributable to parent | 0 | 0 | 0 | -786 |
| Net income | 194,300 | 192,500 | 178,000 | 146,075 |
| Less net income attributable to noncontrolling interest | 1,500 | 600 | 600 | 403 |
| Net income (loss) attributable to shareholders | 192,900 | 191,900 | 177,400 | 145,672 |
| Basic | 1.96 | 1.95 | 1.8 | 1.49 |
| Diluted | 1.96 | 1.94 | 1.79 | 1.48 |
| Weighted average shares outstanding - basic | 98,200,000 | 98,400,000 | 98,400,000 | -197,453,000 |
| Weighted average shares outstanding and share equivalents - diluted | 98,600,000 | 98,800,000 | 98,800,000 | -198,453,000 |
STERIS plc (STE)
STERIS plc (STE)